Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 02, 2022

SELL
$1.91 - $3.98 $57,300 - $119,400
-30,000 Reduced 27.27%
80,000 $169,000
Q4 2021

Feb 10, 2022

BUY
$3.53 - $5.5 $211,800 - $330,000
60,000 Added 120.0%
110,000 $408,000
Q2 2021

Aug 11, 2021

BUY
$6.24 - $8.22 $124,800 - $164,400
20,000 Added 66.67%
50,000 $326,000
Q1 2021

May 11, 2021

SELL
$6.74 - $10.95 $6,740 - $10,950
-1,000 Reduced 3.23%
30,000 $207,000
Q4 2020

Feb 08, 2021

SELL
$3.75 - $10.56 $270,750 - $762,432
-72,200 Reduced 69.96%
31,000 $316,000
Q3 2020

Nov 02, 2020

BUY
$3.5 - $6.2 $3,500 - $6,200
1,000 Added 0.98%
103,200 $361,000
Q1 2020

May 11, 2020

BUY
$1.46 - $7.19 $149,212 - $734,818
102,200 New
102,200 $347,000

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $164M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Iridian Asset Management LLC Portfolio

Follow Iridian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iridian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iridian Asset Management LLC with notifications on news.